These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19544759)

  • 1. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.
    Snedecor SJ; Botteman MF; Bojke C; Schaefer K; Barry N; Pickard AS
    Sleep; 2009 Jun; 32(6):817-24. PubMed ID: 19544759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.
    Botteman MF; Ozminkowski RJ; Wang S; Pashos CL; Schaefer K; Foley DJ
    CNS Drugs; 2007; 21(4):319-34. PubMed ID: 17381185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eszopiclone for late-life insomnia.
    McCrae CS; Ross A; Stripling A; Dautovich ND
    Clin Interv Aging; 2007; 2(3):313-26. PubMed ID: 18044182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eszopiclone: a review of its use in the treatment of insomnia.
    Hair PI; McCormack PL; Curran MP
    Drugs; 2008; 68(10):1415-34. PubMed ID: 18578559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
    Walsh JK; Krystal AD; Amato DA; Rubens R; Caron J; Wessel TC; Schaefer K; Roach J; Wallenstein G; Roth T
    Sleep; 2007 Aug; 30(8):959-68. PubMed ID: 17702264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.
    Goforth HW; Preud'homme XA; Krystal AD
    Sleep; 2014 Jun; 37(6):1053-60. PubMed ID: 24882900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eszopiclone versus zopiclone in the treatment of insomnia.
    Pinto LR; Bittencourt LR; Treptow EC; Braga LR; Tufik S
    Clinics (Sao Paulo); 2016 Jan; 71(1):5-9. PubMed ID: 26872077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
    Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y
    Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
    Pollack MH; Hoge EA; Worthington JJ; Moshier SJ; Wechsler RS; Brandes M; Simon NM
    J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eszopiclone: an update on its use in insomnia.
    Owen RT
    Drugs Today (Barc); 2011 Apr; 47(4):263-75. PubMed ID: 21573250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of eszopiclone in the treatment of insomnia.
    Morin AK; Willett K
    Adv Ther; 2009 May; 26(5):500-18. PubMed ID: 19513631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
    Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S
    Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK
    J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
    Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eszopiclone for insomnia.
    Melton ST; Wood JM; Kirkwood CK
    Ann Pharmacother; 2005 Oct; 39(10):1659-66. PubMed ID: 16131537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J; Trick L; Johnsen S; Roach J; Rubens R
    Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.